n-acetylneuraminic acid has been researched along with Diabetic Glomerulosclerosis in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (38.10) | 18.2507 |
| 2000's | 5 (23.81) | 29.6817 |
| 2010's | 5 (23.81) | 24.3611 |
| 2020's | 3 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, Y; Hua, R; Mao, H; Wang, R; Wang, Y; Yuan, C; Zhang, W | 1 |
| Chen, H; Guo, K; Lu, J; Ma, Y; Pan, P; Wu, M | 1 |
| Ahn, C; Ju, KD; Kang, E; Kang, HG; Kang, M; Kim, HJ; Lee, J; Oh, KH; Ryu, H; Tsogbadrakh, B; Yang, J | 1 |
| Jawed, M; Mahboob, T; Shahid, SM | 1 |
| Eguchi, J; Hida, K; Inoue, K; Iseda, I; Katayama, A; Makino, H; Murakami, K; Nakatsuka, A; Ogawa, D; Ogawa, T; Terami, T; Teshigawara, S; Tone, A; Wada, J; Yamada, M | 1 |
| Anghel, A; Budu, V; Ene, CD; Neagu, M; Nicolae, I; Penescu, M | 1 |
| Duncan, H; Lalloo, S; Maraj, K; Matmungal, V; Matthews, F; Prajapati, B; Samuel, R; Shivananda Nayak, B; Sylvester, P | 1 |
| Bednarek-Skublewska, A; Jakubowska-Solarska, B; Ksiazek, A; Solski, J | 1 |
| Afshariani, R; Bodagkhan, F; Merat, A; Roozbeh, J; Yarmohammadi, H | 1 |
| Mahboob, T; Nawab, SN; Shahid, SM; Shaikh, R | 1 |
| Bhaktha, G; Nayak, SB | 1 |
| Faur, L; Moldovan, C; Motocu, M; Muţiu, G; Onaca, M | 1 |
| Deckert, T; Jensen, JS; Jensen, T; Yokoyama, H | 1 |
| Auersvald, LA; Azhderian, E; Bia, MJ; Friedman, AL; Gruber, J; Lorber, MI; Orias, M; Perez, RV; Sturges, M; Wilson, J | 1 |
| Crook, MA; Ingham, JN; Powrie, JK; Shaw, KM; Taub, NA; Watts, GF | 1 |
| Chen, J; Deckert, M; Gall, MA; Jensen, JS; Parving, HH; Yokoyama, H | 1 |
| Deckert, T; Jensen, JS; Mathiesen, ER; Myrup, B; Rønn, B; Yokoyama, H | 1 |
| Bartásková, D; Kvapil, M; Neumann, M; Spunda, J | 1 |
| Crook, MA; Fuller, JH; Georgino, F; Giorgino, F; Lumb, PJ; Pickup, JC; Webb, DJ | 1 |
| Dohi, K; Dohi, Y; Ishikawa, H; Kanauchi, M; Takenaka, Y | 1 |
| Nanjo, K; Nishimura, S | 1 |
21 other study(ies) available for n-acetylneuraminic acid and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Designing stimuli-responsive upconversion nanoparticles based on a mimetic immunoassay for potential accurate diabetic nephropathy diagnosis.
Topics: Biomarkers; Diabetes Mellitus; Diabetic Nephropathies; Humans; Immunoassay; N-Acetylneuraminic Acid; Nanoparticles; Ninhydrin | 2023 |
Hyposialylated angiopoietin-like-4 induces apoptosis of podocytes via β1 Integrin/FAK signaling in diabetic nephropathy.
Topics: Actin Cytoskeleton; Angiopoietin-Like Protein 4; Animals; Apoptosis; Cell Line; Cell Line, Transformed; Diabetic Nephropathies; Focal Adhesion Protein-Tyrosine Kinases; Glucose; Hexosamines; Humans; Hyperglycemia; Integrin beta1; Male; Mice, Inbred C57BL; N-Acetylneuraminic Acid; Podocytes; Rats, Sprague-Dawley; Signal Transduction; Up-Regulation | 2020 |
Soluble α-klotho anchors TRPV5 to the distal tubular cell membrane independent of FGFR1 by binding TRPV5 and galectin-1 simultaneously.
Topics: Animals; Benzamides; Calcium Channels; Cell Membrane; Diabetic Nephropathies; Endocytosis; Epithelial Cells; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Galectin 1; Kidney; Mice; N-Acetylneuraminic Acid; Piperazines; Pyrazoles; TRPV Cation Channels | 2021 |
Relationship between serum nitric oxide and sialic acid in coexisted diabetes, hypertension and nephropathy.
Topics: Blood Glucose; Blood Pressure; Creatinine; Diabetes Mellitus; Diabetic Nephropathies; Fasting; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Hypertension; Male; Middle Aged; N-Acetylneuraminic Acid; Nitric Oxide; Renal Insufficiency; Urea | 2013 |
Urinary fetuin-A is a novel marker for diabetic nephropathy in type 2 diabetes identified by lectin microarray.
Topics: alpha-2-HS-Glycoprotein; Alpha-Globulins; Biomarkers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Male; Microarray Analysis; Middle Aged; N-Acetylneuraminic Acid; Plant Lectins; Risk | 2013 |
Monitoring Diabetic Nephropathy by Circulating Gangliosides.
Topics: Aged; Albuminuria; Biomarkers; Blood Glucose; Case-Control Studies; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Gangliosides; Glycated Hemoglobin; Humans; Male; Middle Aged; Monitoring, Physiologic; N-Acetylneuraminic Acid; Prospective Studies; Urea | 2016 |
Correlation of microalbumin and sialic acid with anthropometric variables in type 2 diabetic patients with and without nephropathy.
Topics: Adolescent; Adult; Albuminuria; Analysis of Variance; Anthropometry; Biomarkers; Blood Glucose; C-Reactive Protein; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Male; Middle Aged; N-Acetylneuraminic Acid; Trinidad and Tobago | 2008 |
Sialic acid content in erythrocyte membranes of patients on chronic hemodialysis.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Chronic Disease; Comorbidity; Diabetic Nephropathies; Erythrocyte Membrane; Erythropoietin; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; N-Acetylneuraminic Acid; Recombinant Proteins; Renal Dialysis; Smoking | 2009 |
Significance of serum and urine neuraminidase activity and serum and urine level of sialic acid in diabetic nephropathy.
Topics: Adult; Aged; Analysis of Variance; Biomarkers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Male; Middle Aged; N-Acetylneuraminic Acid; Neuraminidase; Young Adult | 2011 |
Glycemic control, dyslipidemia and endothelial dysfunction in coexisted diabetes, hypertension and nephropathy.
Topics: Albuminuria; Blood Glucose; Cholesterol; Creatinine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dyslipidemias; Female; Glycated Hemoglobin; Humans; Hypertension; Male; Middle Aged; N-Acetylneuraminic Acid; Nitric Oxide; Triglycerides; Urea | 2012 |
Relationship between sialic acid and metabolic variables in Indian type 2 diabetic patients.
Topics: Adolescent; Adult; Albuminuria; Asian People; Cholesterol; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; Female; Glycated Hemoglobin; Humans; India; Male; Middle Aged; N-Acetylneuraminic Acid; Triglycerides | 2005 |
Sialic Acid, possible marker of angiopathic complications at diabetics type 2.
Topics: Aged; Biomarkers; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Humans; Hyperlipidemias; Middle Aged; Myocardial Ischemia; N-Acetylneuraminic Acid; Obesity | 2005 |
Serum sialic acid concentration is elevated in IDDM especially in early diabetic nephropathy.
Topics: Adult; Blood Glucose; Blood Sedimentation; Creatinine; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Fibrinogen; Glycated Hemoglobin; Humans; Male; Middle Aged; N-Acetylneuraminic Acid; Sialic Acids | 1995 |
Serum sialic acid, a risk factor for cardiovascular disease, improves following pancreas transplantation.
Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Nephropathies; Humans; Kidney Transplantation; N-Acetylneuraminic Acid; Pancreas Transplantation; Risk Factors; Sialic Acids | 1995 |
Serum sialic acid and the long-term complications of insulin-dependent diabetes mellitus.
Topics: Adult; Age of Onset; Albuminuria; Biomarkers; Creatinine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Humans; N-Acetylneuraminic Acid; Proteinuria; Sialic Acids | 1996 |
Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy.
Topics: Aged; Albuminuria; Analysis of Variance; Biomarkers; Blood Pressure; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Creatinine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Electrocardiography; Female; Hemoglobin A; Humans; Lipids; Male; Middle Aged; N-Acetylneuraminic Acid; Prevalence; Reference Values; Risk Factors; Sialic Acids; Smoking | 1996 |
Raised serum sialic acid concentration precedes onset of microalbuminuria in IDDM. A 10-year follow-up study.
Topics: Adult; Albuminuria; Biomarkers; Blood Pressure; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Male; N-Acetylneuraminic Acid; Predictive Value of Tests; Risk Assessment; Sialic Acids; Time Factors; von Willebrand Factor | 1996 |
[Serum levels of sialic acid in patients with type 1 diabetes mellitus in relation to the incidence of late complications].
Topics: Adult; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabetic Retinopathy; Humans; N-Acetylneuraminic Acid; Risk Factors | 1996 |
Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications Study.
Topics: Adult; Albuminuria; Body Constitution; Cholesterol; Coronary Disease; Creatinine; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Exercise; Female; Glycated Hemoglobin; Humans; Hypertension; Logistic Models; Male; N-Acetylneuraminic Acid; Risk Factors; Smoking; Triglycerides | 2001 |
Diagnostic significance of urinary sialic acid in diabetic nephropathy.
Topics: Adult; Aged; Biomarkers; Biopsy; Diabetic Nephropathies; Female; Humans; Kidney; Male; Middle Aged; N-Acetylneuraminic Acid; Sialic Acids | 1992 |
[Clinical significance of serum sialic acid in the diagnosis of diabetic diseases].
Topics: Blood Glucose; Blood Platelets; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Erythrocyte Membrane; Humans; N-Acetylneuraminic Acid; Sialic Acids; Spectrophotometry | 1990 |